TRDA compared with SKYE: revenue, margins and what each company keeps, and the suppliers and customers both name

TRDAEntrada Therapeutics, Inc.

Mkt capRevenueRevenue

SKYESkye Bioscience, Inc.

Mkt capRevenueRevenue

Compare

TRDAEntrada Therapeutics, Inc.

SKYESkye Bioscience, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TRDAEntrada Therapeutics, Inc.

4.59▲+1.20%

Mkt cap$176.6MRevenue$898,000Q2 FY26Revenue$25MFY25

SKYESkye Bioscience, Inc.

1.29▲+0.78%

Regular sessionSep 2 '83

Mkt cap$5.7MRevenue—Revenue—

Compare

Regular sessionSep 2 '83

TRDAEntrada Therapeutics, Inc.

SKYESkye Bioscience, Inc.

4.59▲+1.20%

Price

1.29▲+0.78%

$176.6M

Mkt cap

$5.7M

Q2 FY26$898,000

Revenue

—

FY25$25M

Revenue

—

TRDA4.59▲+1.20%vsSKYE1.29▲+0.78%Regular sessionSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TRDA: latest quarter is a loss; flow not drawable. SKYE: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TRDA 3

VRTXVertex Pharmaceuticalscustomer

—Ohio State Innovation Foundationunlistedsupplier

—Pierrepont Therapeuticsunlistedcustomer

Shared 0

No shared counterparties.

Only SKYE 1

HALOHalozymesupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

TRDA, solidSKYE, dashed